To uncover additional independent clinical features related to prognosis, a multifactorial Cox regression analysis was conducted on various factors, including IPI score, clinical stage, Ki-67 expression level, rituximab application status, LDH expression level, and the presence of MetS. This evidence concerns the gene MKI67 and metabolic syndrome.